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Poliovirus, a picornavirus family ember, requires the processing ofits poly-protein by its own cystein¢ protcinasc for replication. Oryzacystatin-I 
and oryza~statin-lI, proteinaceous cy teine proteinase inhibitors (cystatins) of rice seed orisin, were found to inhibit the replication of oliovirus 
effectively ininfected Veto cells in vitro. Truncated oryzacystatin-I, which lacks the NH.,-terminal 25 amino acid residues of the intact protein, 
is an even more ffective inhibitor, eliciting its effect at concentrations of less than 0.25 nmol/ml. The low molecular weight cysteine proteinase 
inhibitors, E-64, E-64C and loxistatin, showed no anti-viral effect at any concentration investigated. 
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1. INTRODUCTION 
The replication of members of  the picornavirus fam- 
ily0 including poliovirus, requires the processing of the 
viral poly-proteins in the cytoplasm of infected cells 
[1,2]. The capsid proteins of poliovirus consist of VP1- 
VP4, along with VPg as a minor component; hey are 
formed by processing the poly-protein at nine glu- 
tamine.-glyeine bonds, two tyrosine-glycine bonds and 
one asparagine-serine bond [3]. Various protdnases are 
involved in this processing [4]; in particular, a cysteine 
proteinase is involved in processing at the glutamine- 
glycine bonds [5]. If internalized, therefore, cystatins, a 
family of proteinaceous cysteine proteinase inhibitors, 
might be excepted to inhibit the replication of  picor- 
naviruses in infected cells. In fact, egg white cystatin has 
been shown to exhibit this type of inhibitory action [6]. 
Recently, cystatin C, which exists in human blood, tears 
and bone marrow, has also been reported to have an 
antiviral effect against herpesvirus [7]. 
Oryzacystatins, which occur in rice seeds, are the first 
well-defined cystatins of plant origin [8,9]. Oryzacy- 
statins comprise two known molecular species, oryzacy- 
statin-I (PC-I) [10] and oryzaeystatin-II (OC-II) [11], 
which inhibit different cysteine proteinases, respectively 
papain and cathepsin H [11]. Recently, we reported that 
truncated PC-I ,  which lacks :21 amino acid residues 
from the NH2-terminus, still retains its papain-inhib- 
itory activity [I 2]. 
In this study, we investigated the anti-polioviral 
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effects of  oryzacystatin and its truncation mutant in 
comparison with egg white cystatin and low molecular 
weight cysteine proteinase inhibitors. Here we report 
the results with special emphasis on the el'feet of  
truncated OC-I (tOC-I), a molecular species that may 
have a practical use as an antiviral agent. 
2. MATERIALS  AND METHODS 
2.1. Viruses and cells 
Attenuated poliovirus (type 1), vesicular stomatitis virus (VgV, New 
Jersey strain), and influenza virus (Kumamoto Y567(H2N2) strain), 
were obtained fi'om stocks at Kumamoto University Medical School. 
Veto, L929 and a dog kidney cell line (MDCK) were used as host cells. 
The cells were cultured in Eagle's minimal essential medium (MEM, 
Gibco Ltd.) containing 10% fetal calf serum, and 100 ,ug/ml eaeil of
penicillin and streptomycin. 
2.2. Preparation of cystatins 
OC-I and OC-II were expressed by incorporating their eDNA 
clones into E. ¢oli [11]. The expre~ion products were purified by 
sequential chromatographies on DEAE-Sephadex, Mono Q (FPLC 
system) and ODS columns (HPLC). Truncated OC.I (tOC-I), which 
lacks 25 amino acid residues from the NHz-terminal, was prepared 
similarly [12]. E~ white cystatin was purchased from Takara Sh~o 
Co., Kyoto, Japan. The low molecular weight ¢ystein¢ proteinas¢ 
inhibitors, E.64 113], E-64.c 114], and ioxistatin [IS], were obtained 
from Taisyo S¢iyaku Co. 
2.3. Antiviral effect 
C~lls were cultured until they formed a monolayer, infected with 
viruses at MOI 0.1, and then incubated for 30 min at 37"C. The virus 
SUSl~nsions were then removed and the ¢~lls were incubated for an- 
other 18 h at 37°C in medium containing various concentration of 
cystatins or inhibitors. Inhibition of the viral cytopathic effect (CPE) 
by cystatins was uhen observ.-'d with a microscope. The supernatant 
ofe~ch culture medium was subj~ted to a plaque forming assay. Cell  
were then treat~l with a given amount of the superaatant u~d for the 
CPE inhibitory effect. After incubation for 30 rain at 37"C, the cells 
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Table l 
Antiviral activity of various proteinaegoas inhibitors 
lnhibitors Polio virus VSV 
(virus yield, PFU/ml) 
Oryzacystatin-I 1,0xl0 ~ 2,3x10 ~ 
Oryzacystatin-ll 1,0xl0 s 2,0×10 ~
Truncated oryzacystatin.l 1,2x10 ~ 2,4x10 ~ 
Egg white cystatin 1.0xl0 ~ 2,0x10 ~ 
Soy bean trypsin inhibitor 4.1x107 3.3x10 ~ 
E-64 5.4x10 ~ 3,1x10 ~ 
E -64C 3.3xI0 ~ 3.0x10 ~ 
Loxistatin 3,5x10 7 3,0xi0 ~ 
Pepstatin 3.4x10 ~ 2,9xi 0 ~ 
None (control) 3,5x10 ~ 3,0x10 ~ 
The concentration of each inhibitor i~ 8 nrnol/ml in medium 
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were covered with Eagle's MEM containing 10% FCS and 0.9% agar 
and incubated for 48 h at 37'C until plaques formed. + CYSTATIN 
3. RESULTS 
Table I shows the inhibition of the viral CPE  by 
various cysteine proteinase inhibitors. OC-I and OC-II 
are apparently potent antiviral agents against poliovirus 
at a concentration of 8 nmol/ml, similar to the inhib- 
itory effect of egg white cystatin reported previously [6]. 
The truncated oryzacystatin-I mutant, tOC-I, is also 
effective. Furthermore, OC-I, OC-II and tOC-I also 
have antiviral activities against VSV, although the 
effects are far weaker than observed with poliovirus. 
The effect of oryzacystatins on influenza virus infection 
was examined using MDCK cells, but the results were 
not so remarkable as in the case of poliovirus (data not 
shown). On the other hand, E-64 had no effect. We also 
tested the effects of E-64C and loxistatin, which are 
designed to penetrate the cell membrane more effec- 
Table II 
Anti-polioviral activities of various cystatins 
Cystatins Concentrations Virus yield (PFU/ml) 
(nmol/ml) 
Oryzacystatin-I 8 1.0xl0 ~ 
4 1.2x10 ~ 
2 1.0xl0 ~ 
1 3.0xlO ~ 
Oryzacystatin-II 8 1,0~10 s 
4 5.0x10 ~ 
2 6.5x10 ~ 
1 2.3X107 
Truncated oryzacy- 2 1.2xlO s
statin-I 1 9.0~10 ~
0.5 1.6×10 ~
0.25 2.8x107 
]~gg white cystat in 8 1.0xl0 ~ 
E-64 8 5,4x10 ~ 
None (control) - 3,5x10 ~ 
Species, poliovirus type I 
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Fig, 1, Cell morphology following infection by poliovirus, (A) Cells 
infected with poliovirus and cultured in medium containing oryza~- 
statins at 8 nmol/ml. (B) Infected cells cultured in medium without 
oryzacystatins, The cell-degenerating cytopathic effect (CPE) is ap- 
parent in B. Magnification xl00 
tively than E-64. E-64C and loxistatin, however, also 
showed no antiviral effect on any viru~s investigated, 
even at concentrations of 8,000 nmol/rnl or more. Fig. 
1 illustrates the morphology of virus-infected cells in the 
presence or absence of eystatins. Cells cultured in the 
absence of eystatins are damaged by the infecting virus 
(CPE), whereas those cultured in the presence of a suffi. 
cient amount of ¢ystatin remain viable and vivid in 
appearance. 
However, when cells are cultured first in medium 
containing cystatin at a concentration of 8 nmol/ml and 
the cystatin is removed prior to subsequent viral infec- 
tion, no protection against viral damage is observed 
(data not shown). Thus, the antiviral effect requires the 
49 
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presence of cystatins during the later stages of viral 
infection. 
Table II shows the effects of cystatins on growth 
inhibition by poliovirus based on the plaque forming 
unit (PFU) assay. When OC-l, OC-II or egg white cys- 
tatin is added to the culture medium at a concentration 
greater then 4 heel/el ,  the values (PFU/ml) are re- 
duced by approximately two orders of magnitude or 
more compared with the control. The minimum effec- 
tive concentration f cystatin is at a concentration f
about 1.0 nmol/ml, tOC-I is a better inhibitor than na- 
tive OC-I, since ven at a concentration f 0.25 heel /e l  
its significant inhibitory activity remains. 
4. DISCUSSION 
In this report he antiviral activity of oryzacystatins 
against infectious poliovirus is demonstrated. The 
mechanism for this effect is asstamed to involve the in- 
hibition of the viral cysteine proteinase which take part 
in processing the poly-protein. Contrary to expectation, 
the low molecular weight cysteine proteinase inhibitors, 
E-64, E-64-C and loxistatin, have no effect on viral 
replication. There are at least two ways to explain this 
result. First, E-64 and its analogues might be unable to 
inhibit viral proteinases even though they effectively 
inhibit typical cysteine proteinases such as papain and 
cathepsin H. Even though it contains cysteine and his- 
tidine residues in its active site, cysteine proteinase of 
poliovirus might be a prototype of either a serine or 
cysteine proteinase, in which ease it would resemble 
ehymotrypsin rather than papain [16,17]. Compared to 
E-64, cystatins might have a wider inhibitory spectrum 
allowing them to inhibit viral cysteine proteinases. The 
second possibility is that E-64 and its analogues might 
penetrate he cell membrane only slightly and thus have 
no chance of interacting with viral cysteine proteinases. 
This possibility is, however, unlikely, because E-64 and 
its derivatives are used in the treatment of muscular 
dystrophy in which intracellular cathepsins are in- 
hibited. Cystatins are thought to be unable to penetrate 
cell membranes by themselves; but they could be inter- 
nalized into the cytoplasm of virus.infected cells if 
changes in the cell membrane structure occur upon viral 
infection. This type of phenomenon has been ob~,)rved 
in T lymphocyte cells infected by HIV virus [18]. Also, 
many small and large proteins are known to be internal. 
ized into cells by endocytosis. 
Oryzacystatins are synthesized in rice seeds during 
the early stages of seed maturation. Considering the 
meaning for the existence of oryzacystatins i  dee seeds, 
it seems possible that they might play an important role 
in protecting rice seeds from attack by various plant 
viruses, all of which are known to be RNA viruses. In 
vivo experiments are necessary to obtain more detailed 
information. 
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